AMEX · USBC

USBC, Inc.

$0.32 -$0.02 (-5.36%) 1D After hours

Key Metrics

$130.42M
Market cap
P/E · TTM
Revenue · TTM
−$20.89M
Net income
EPS · TTM $-7.18
Dividend yield
Free cash flow
Beta · 1Y 2.07
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 3
    From its May 12 high, the share price fell 57%.

    Peak close $0.70 on May 12; trough close $0.30 on Jun 3. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -57%
  • May 18
    The stock moved -19.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 18
  • May 12
    The stock moved +38.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$130.42M
Enterprise value
Shares outstanding388.1M
52-wk range$0.29 – $2.23
Avg volume · 20D1.2M
Net cash
Book value / share$20.59
IndustryFinance Services
ExchangeAMEX
About USBC, Inc.
IPO dateFeb 27, 2006
Employees31

USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -34.9% · —

Financial Health

Current ratio0.32
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital−$7.25M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings